首页> 外文OA文献 >A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

【2h】

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

机译：拓扑替康和口服胸苷（Toposioomerase I和II抑制剂）在治疗小细胞肺癌患者中的一期I-II研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tony S. K. Mok; Herman Wong; Benny Zee; Kwok Hung Yu; Thomas W. T. Leung; Tak Wai Lee; Anthony Yim; Anthony T. C. Chan; Winnie Yeo; Karen Chak; Philip Johnson;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancer. [J] . Baka S, Agelaki S, Kotsakis A, Anticancer Research: International Journal of Cancer Research and Treatment . 2010,第7期

机译：III期研究比较顺铂-依托泊苷和拓扑替康作为小细胞肺癌的一线治疗的顺序和交替给药。
2. Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study. [J] . Mavroudis D, Pavlakou G, Blazoyiannakis G, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2003,第1期

机译：在患有广泛期小细胞肺癌的患者中，顺铂-依托泊苷顺序给药，然后给予拓扑替康。多中心II期研究。
3. Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group. [J] . Ignatiadis M, Mavroudis D, Veslemes M, Clinical lung cancer . 2005,第3期

机译：顺铂/依托泊苷和拓扑替康的顺序或交替给药作为广泛期小细胞肺癌的一线治疗：希腊肿瘤学研究小组的III期试验的初步结果。
4. PHASE I/II TRIAL OF DUAL AGENT POLYAMINE DEPLETION THERAPY FOR FELINE ORAL SQUAMOUS CELL CARCINOMA [C] . Katherine A Skorupski, Thomas OBrien, Mark Burns, Annual conference of the Veterinary Cancer Society . 2008

机译：双药剂多胺耗竭治疗猫鳞状鳞状细胞癌的I / II试验
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer. [O] . M. Ando, K. Eguchi, T. Shinkai, 1997

机译：对转移性非小细胞肺癌依序给予拓扑异构酶I抑制剂（伊立替康）和拓扑异构酶II抑制剂（依托泊苷）的I期研究。
7. Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane - Results from a multicenter phase I/II study [O] . Gronlund, B, Engelholm, SA, Horvath, G, 2005

机译：用铂 - 紫杉烷预处理的复发性卵巢癌中的顺序拓扑替康和口服依托泊苷 - 多中心I / II期研究结果

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅